Founded on pioneering research and industry leadership, ARxIUM® is committed to overcoming the most complex challenges ...

Let’s talk about 340B, the drug pricing problem that you may not have heard of, but the one that seems to have swallowed the federal budget. The program started as an attempt to help hospitals that ...

Too many hospitals take advantage of 340B, intended to make medications affordable for low-income patients. A New York proposal would make things worse. Credit: Getty Images. Millions of New Yorkers ...

I am a proud health care professional here in Delaware, and I am calling on leaders in Washington, D.C. to support the 340B ACCESS Act. This legislation is urgently needed to restore accountability to ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

On October 30, HRSA announced that it had selected eight drug manufacturers to participate in its 340B Rebate Model Pilot Program, spanning 10 drugs representing a range of widely used therapies.

Since 1992, the 340B drug discount program has entitled certain federal grantee clinics and hospitals (called “covered entities”) to purchase outpatient drugs at substantial discounts. The discounted ...

What happens when the nearest major city is at least four hours away, but your child or aging parent needs access to immediate care? For tens of thousands of families across Colorado’s Western Slope, ...

The 340B Drug Pricing Program was designed to help safety net providers serve low-income patients, but it has since ballooned into a multibillion-dollar system dominated by large health systems — with ...

The Trump administration has approved eight drugmakers' rebate plans for a controversial 340B drug discount pilot program that kicks off Jan. 1. The 340B Rebate Model Pilot Program, unveiled this ...

This story was originally published on Healthcare Dive. To receive daily news and insights, subscribe to our free daily Healthcare Dive newsletter. Federal regulators have greenlit eight drugmaker ...